Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial
2017 ◽
Vol 18
(9)
◽
pp. 1192-1201
◽
2017 ◽
Vol 30
◽
pp. 84-90
◽
2018 ◽
Vol 19
(10)
◽
pp. 1404-1416
◽